Learn More
≥98% HPLC PURITY
Tesamorelin
2mg / 10 VIALS
MINDTEK · RESEARCH USE ONLY
RESEARCH USE ONLY COA VERIFIED SOLUTION PHASE

Tesamorelin

Stabilised GHRH Analogue

Synthetic 44-amino-acid GHRH analogue bearing an N-terminal hexenoyl group that resists enzymatic degradation. Stimulates endogenous GH secretion, with research focused on visceral adipose reduction.

MW: 5135.76 Da CAS: 218949-48-5 Per Vial: 2mg Kit: 10 Vials
SELECT QUANTITY
1 Vial $125Order
3 Vials Save 8%$115 eaOrder
5 Vials Save 20%$100 eaOrder
10 Vials Best Value$85 eaOrder

Mechanism of Action

Tesamorelin is a stabilised analogue of human GHRH(1-44). The N-terminal hexenoyl modification slows proteolysis, prolonging GHRH-receptor engagement on pituitary somatotrophs and raising pulsatile GH and downstream IGF-1. Research has focused on reduction of visceral adipose tissue.

⚡
Stabilised GHRH
Hexenoyl modification resists enzymatic degradation.
🔬
GH / IGF-1 Axis
Sustained GHRH-receptor engagement raises pulsatile GH.
🧬
Visceral Adipose Focus
Reduction of visceral fat documented in controlled trials.

Research Evidence

DATA = directly reported in cited study · INFERENCE = derived · SPECULATION = hypothesis

Falutz J et al. (2007) N Engl J Med 357(23)DATA
Tesamorelin reduced visceral adipose tissue vs. placebo over 26 weeks in a randomised controlled trial (DATA).
Stanley TL et al. (2014) JAMA 312(4)DATA
Tesamorelin reduced visceral and hepatic fat vs. placebo in adults with HIV-associated lipodystrophy (DATA).
Ishida J et al. (2020) JCSM Rapid Commun 3(1)DATA
Reviews GHRH-analogue pharmacology and the tesamorelin GH-axis mechanism (DATA).

Certificate of Analysis

Every Mindtek batch is independently tested before release. We were among the first peptide suppliers in Southeast Asia to implement mandatory third-party HPLC verification — a standard, not an exception.

HPLC Purity≥98.0%
Bacterial Endotoxins≤5 EU/mg
Water Content (Karl Fischer)≤8.0%
Peptide Content≥80%
StandardUSP/EP

Research Protocol Reference

For laboratory research use only — not for human or veterinary use.

💧
Reconstitution
Add sterile bacteriostatic water (0.9% benzyl alcohol) slowly against the vial wall. Gently swirl — do not vortex. Allow 5 min for complete dissolution.
🧊
Storage
Store solution-phase at -20°C. Post-reconstitution: maintain at 2–8°C, use within 28 days. Protect from light. Avoid repeated freeze-thaw cycles.
📐
Administration
SubQ or IM administration in standard research protocols. Insulin syringe recommended for precise dosing. Refer to published literature for compound-specific protocols.

Frequently Asked Questions

What is Tesamorelin?
Tesamorelin is a synthetic 44-amino-acid GHRH analogue (a stabilised GHRH(1-44) analogue) based on human GHRH. Research applications: growth-hormone axis and body-composition research. Research use only.
How is Mindtek Tesamorelin produced?
Synthesised via solid-phase peptide synthesis (SPPS). Each batch: HPLC purity verification (≥99.3%), mass spectrometry identity, endotoxin testing prior to release.
Storage requirements?
Store solution-phase Tesamorelin at -20°C. Post-reconstitution with sterile BAC water: 2–8°C, use within 28 days. Avoid repeated freeze-thaw cycles.

Ready to Order Tesamorelin?

Mindtek ships solution-phase, independently verified research compounds to qualified researchers globally. First in Southeast Asia.

Place an Order Research Hub